Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Which Three-Dimensional Characteristics Make Efficient Inhibitors of Protein–Protein Interactions?
Mélaine A. Kuenemann, Laura M. L. Bourbon, Céline M. Labbé, et al.
Journal of Chemical Information and Modeling (2014) Vol. 54, Iss. 11, pp. 3067-3079
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Predictive compound accumulation rules yield a broad-spectrum antibiotic
Michelle F. Richter, Bryon Drown, Andrew P. Riley, et al.
Nature (2017) Vol. 545, Iss. 7654, pp. 299-304
Open Access | Times Cited: 775
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions
Christopher A. Lipinski
Advanced Drug Delivery Reviews (2016) Vol. 101, pp. 34-41
Closed Access | Times Cited: 479
Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges
Isabella Alvim Guedes, Felipe Siconha S. Pereira, Laurent E. Dardenne
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 258
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
David Lagorce, Dominique Douguet, Maria A. Miteva, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 196
New machine learning and physics-based scoring functions for drug discovery
Isabella Alvim Guedes, André M. S. Barreto, Diogo Marinho, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 161
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
Luca Laraia, Grahame J. McKenzie, David R. Spring, et al.
Chemistry & Biology (2015) Vol. 22, Iss. 6, pp. 689-703
Open Access | Times Cited: 144
Flexibility and small pockets at protein–protein interfaces: New insights into druggability
Harry Jubb, Tom L. Blundell, David B. Ascher
Progress in Biophysics and Molecular Biology (2015) Vol. 119, Iss. 1, pp. 2-9
Open Access | Times Cited: 144
Targeting intrinsically disordered proteins at the edge of chaos
Hao Ruan, Qi Sun, Weilin Zhang, et al.
Drug Discovery Today (2018) Vol. 24, Iss. 1, pp. 217-227
Closed Access | Times Cited: 115
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
Stephani Joy Y. Macalino, Shaherin Basith, Nina Abigail B. Clavio, et al.
Molecules (2018) Vol. 23, Iss. 8, pp. 1963-1963
Open Access | Times Cited: 101
The impact of in silico screening in the discovery of novel and safer drug candidates
Didier Rognan
Pharmacology & Therapeutics (2017) Vol. 175, pp. 47-66
Open Access | Times Cited: 94
In silico structure-based approaches to discover protein-protein interaction-targeting drugs
Woong‐Hee Shin, Charles Christoffer, Daisuke Kihara
Methods (2017) Vol. 131, pp. 22-32
Open Access | Times Cited: 76
Rhodium-Catalyzed [4 + 1] Cyclization via C–H Activation for the Synthesis of Divergent Heterocycles Bearing a Quaternary Carbon
Xiaowei Wu, Haitao Ji
The Journal of Organic Chemistry (2018) Vol. 83, Iss. 8, pp. 4650-4656
Open Access | Times Cited: 65
Access to a Structurally Complex Compound Collection via Ring Distortion of the Alkaloid Sinomenine
Alfredo García, Bryon Drown, Paul J. Hergenrother
Organic Letters (2016) Vol. 18, Iss. 19, pp. 4852-4855
Open Access | Times Cited: 57
iPPI-DB: an online database of modulators of protein–protein interactions
Céline M. Labbé, Mélaine A. Kuenemann, Barbara Zarzycka, et al.
Nucleic Acids Research (2015) Vol. 44, Iss. D1, pp. D542-D547
Open Access | Times Cited: 55
In silico design of low molecular weight protein–protein interaction inhibitors: Overall concept and recent advances
Mélaine A. Kuenemann, Olivier Spérandio, Céline M. Labbé, et al.
Progress in Biophysics and Molecular Biology (2015) Vol. 119, Iss. 1, pp. 20-32
Closed Access | Times Cited: 54
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors
Davide Benedetto Tiz, Žiga Skok, Martina Durcik, et al.
European Journal of Medicinal Chemistry (2019) Vol. 167, pp. 269-290
Closed Access | Times Cited: 44
Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists
Davide Benedetto Tiz, D. Kikelj, Nace Zidar
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 6, pp. 497-507
Closed Access | Times Cited: 44
Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions
Nicolas Bosc, Christophe Müller, Laurent Hoffer, et al.
ACS Chemical Biology (2020) Vol. 15, Iss. 6, pp. 1566-1574
Open Access | Times Cited: 37
Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors
Mélaine A. Kuenemann, Céline M. Labbé, Adrien Henri Cerdan, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 27
pdCSM-PPI: Using Graph-Based Signatures to Identify Protein–Protein Interaction Inhibitors
Carlos H. M. Rodrigues, Douglas E. V. Pires, David B. Ascher
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 11, pp. 5438-5445
Closed Access | Times Cited: 21
Analysis of physicochemical properties of protein–protein interaction modulators suggests stronger alignment with the “rule of five”
Jia Q. Truong, Ashwin George, Jessica K. Holien
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1731-1749
Open Access | Times Cited: 17
Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2
Douglas R. Houston, Li-Hsuan Yen, S. Pettit, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0121424-e0121424
Open Access | Times Cited: 16
Discovery of Inhibitors for Proliferating Cell Nuclear Antigen Using a Computational-Based Linked-Multiple-Fragment Screen
Matthew Bartolowits, Jonathon M. Gast, Ashlee J. Hasler, et al.
ACS Omega (2019) Vol. 4, Iss. 12, pp. 15181-15196
Open Access | Times Cited: 16
Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces
Natesh Singh, Ludovic Chaput, Bruno O. Villoutreix
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 8, pp. 3910-3934
Open Access | Times Cited: 15
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors
Guangyan Zhou, Shidong Chu, Ariana Nemati, et al.
European Journal of Medicinal Chemistry (2018) Vol. 161, pp. 533-542
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top